New York, October 6 (RHC)-- In the United States, Johnson & Johnson has asked the Food and Drug Administration to authorize booster shots for its coronavirus vaccine. An FDA advisory panel will review the request at a meeting next week when it might also consider a booster shot from Moderna.
Meanwhile, AstraZeneca has requested emergency use authorization from the FDA for its coronavirus antibody therapy, which the company claims reduces the chances of developing COVID by 77%.
